SCHEMBL79785

SCHEMBL79785

OCCCc1ccc2c(c1)OCO2

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 2/20 0.64
TAAR1 Q96RJ0 1/20 0.62
HDAC1 Q13547 2/20 0.57
HDAC3 O15379 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
CYP3A4 P08684 4/20 0.57
CYP2D6 P10635 1/20 0.57
TRPV1 Q8NER1 1/20 0.54
CYP1A2 P05177 2/20 0.51
ALDH1A1 P00352 2/20 0.51
SLC6A4 P31645 1/20 0.51
MAPT P10636 1/20 0.51
GAA P10253 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809247 0.95 CALM1 (0.62) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL30101936 0.95 CALM1 (0.62) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL26919 0.93 HDAC1 (0.62) CALM1TAAR1HDAC1HDAC3HDAC2
Hydrogen Sulfide SCHEMBL28114002 0.91 HDAC1 (0.61) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL11851172 0.89 CALM1 (0.51) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL834910 0.89 TAAR1 (0.67) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL29644736 0.89 TAAR1 (0.67) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL28867370 0.89 CALM1 (0.60) CALM1TAAR1HDAC1HDAC3HDAC2
SCHEMBL108050 0.88 CALM1 (0.72) CALM1TAAR1HDAC1HDAC3HDAC2
Propionic Acid SCHEMBL28643063 0.88 HDAC1 (0.54) CALM1TAAR1HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563508-A2 DELIVERY PARTICLE The Procter & Gamble Company (US) 2013-03-06 EP claimed
CN-102892492-A Delivery particle PROCTER & GAMBLE 2013-01-23 CN claimed
CN-102617543-A Synthesis methods for piperonyl ethanol and derivatives thereof UNIV TIANJIN SCIENCE & TECH 2012-08-01 CN claimed
US-20110268802-A1 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY 2011-11-03 US claimed
WO-2010079468-A2 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO claimed
EP-4747001-A2 SILICA CAPSULES The Procter & Gamble Company (US) 2026-05-27 EP disclosed
US-12478942-B2 Methods of making capsules THE PROCTER & GAMBLE COMPANY (US) 2025-11-25 US disclosed
EP-3955890-B1 CAPSULES PROCTER & GAMBLE (US) 2025-07-16 EP disclosed
US-12343696-B2 Capsules THE PROCTER & GAMBLE COMPANY (US) 2025-07-01 US disclosed
US-20250107973-A1 SILICA CAPSULES THE PROCTER & GAMBLE COMPANY 2025-04-03 US disclosed
WO-2025019299-A2 SILICA CAPSULES THE PROCTER & GAMBLE COMPANY (US) 2025-01-23 WO disclosed
US-12133906-B2 Delivery particle THE PROCTER & GAMBLE COMPANY (US) 2024-11-05 US disclosed
EP-0487510-A1 Pharmaceutically active amines THE UPJOHN COMPANY (US) 1992-05-27 EP disclosed
EP-0358676-A1 PHARMACEUTICALLY ACTIVE AMINES THE UPJOHN COMPANY (US) 1990-03-21 EP disclosed
EP-0293078-A1 Pharmaceutically active amines THE UPJOHN COMPANY (US) 1988-11-30 EP disclosed
WO-1988008424-A1 PHARMACEUTICALLY ACTIVE AMINES THE UPJOHN COMPANY (US) 1988-11-03 WO disclosed
CN-86100669-A The synthetic organic polymers that is used for selective flocculating floatation of titanium and iron ores 1987-08-05 CN disclosed
US-4058607-A DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES AIRWICK INDUSTRIES, INC. (US) 1977-11-15 US disclosed
US-3962282-A JUVENILE HORMONE MIMICS ELI LILLY AND COMPANY (US) 1976-06-08 US disclosed
US-3962415-A Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer AIRWICK INDUSTRIES, INC. (US) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250107973-A1 SILICA CAPSULES SRI, MCM4, RCC1 CALM1 1891/4885TAAR1 3513/4885HDAC1 560/4885
US-20110268802-A1 DELIVERY PARTICLE LIPA, CHMP4B, SLC46A1 CALM1 2250/4885TAAR1 3178/4885HDAC1 3698/4885
US-12133906-B2 Delivery particle LIPA, CHMP4B, SLC46A1 CALM1 2250/4885TAAR1 3178/4885HDAC1 3698/4885
US-12478942-B2 Methods of making capsules FUT6, FUT5, LIPA CALM1 828/4885TAAR1 3689/4885HDAC1 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.